Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Clinical Pediatric Hematology-Oncology ; : 112-115, 2013.
Article in Korean | WPRIM | ID: wpr-130763

ABSTRACT

A 10-year old girl diagnosed as severe aplastic anemia was transplanted with peripheral stem cells from a CMV seropositive full matched unrelated donor. The conditioning regimen consisted of busulfan, fludarabine, and anti-thymocyte globulin (ATG). At D+114, abdominal pain, fever, and blood-tinged watery diarrhea developed. At D+116, pneumatosis intestinalis (PI) was detected on simple abdominal X-ray and computed tomography (CT). Ganciclovir was started intravenously because CMV antigenemia was detected at D+117. Two days later, PI sign disappeared on simple abdominal X-ray, and hematochezia began to decrease. CMV antigenemia disappeared 10 days after starting ganciclovir. We describe a 10-year old girl with severe aplastic anemia who developed PI in the presence of CMV infection and gastro-intestinal graft-versus-host-disease (GVHD) after allogeneic stem cell transplantation and was treated successfully with ganciclovir.


Subject(s)
Female , Humans , Abdominal Pain , Anemia, Aplastic , Antilymphocyte Serum , Busulfan , Diarrhea , Fever , Ganciclovir , Gastrointestinal Hemorrhage , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Stem Cell Transplantation , Stem Cells , Unrelated Donors , Vidarabine
2.
Clinical Pediatric Hematology-Oncology ; : 112-115, 2013.
Article in Korean | WPRIM | ID: wpr-130758

ABSTRACT

A 10-year old girl diagnosed as severe aplastic anemia was transplanted with peripheral stem cells from a CMV seropositive full matched unrelated donor. The conditioning regimen consisted of busulfan, fludarabine, and anti-thymocyte globulin (ATG). At D+114, abdominal pain, fever, and blood-tinged watery diarrhea developed. At D+116, pneumatosis intestinalis (PI) was detected on simple abdominal X-ray and computed tomography (CT). Ganciclovir was started intravenously because CMV antigenemia was detected at D+117. Two days later, PI sign disappeared on simple abdominal X-ray, and hematochezia began to decrease. CMV antigenemia disappeared 10 days after starting ganciclovir. We describe a 10-year old girl with severe aplastic anemia who developed PI in the presence of CMV infection and gastro-intestinal graft-versus-host-disease (GVHD) after allogeneic stem cell transplantation and was treated successfully with ganciclovir.


Subject(s)
Female , Humans , Abdominal Pain , Anemia, Aplastic , Antilymphocyte Serum , Busulfan , Diarrhea , Fever , Ganciclovir , Gastrointestinal Hemorrhage , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Stem Cell Transplantation , Stem Cells , Unrelated Donors , Vidarabine
3.
Clinical Pediatric Hematology-Oncology ; : 112-115, 2013.
Article in Korean | WPRIM | ID: wpr-788496

ABSTRACT

A 10-year old girl diagnosed as severe aplastic anemia was transplanted with peripheral stem cells from a CMV seropositive full matched unrelated donor. The conditioning regimen consisted of busulfan, fludarabine, and anti-thymocyte globulin (ATG). At D+114, abdominal pain, fever, and blood-tinged watery diarrhea developed. At D+116, pneumatosis intestinalis (PI) was detected on simple abdominal X-ray and computed tomography (CT). Ganciclovir was started intravenously because CMV antigenemia was detected at D+117. Two days later, PI sign disappeared on simple abdominal X-ray, and hematochezia began to decrease. CMV antigenemia disappeared 10 days after starting ganciclovir. We describe a 10-year old girl with severe aplastic anemia who developed PI in the presence of CMV infection and gastro-intestinal graft-versus-host-disease (GVHD) after allogeneic stem cell transplantation and was treated successfully with ganciclovir.


Subject(s)
Female , Humans , Abdominal Pain , Anemia, Aplastic , Antilymphocyte Serum , Busulfan , Diarrhea , Fever , Ganciclovir , Gastrointestinal Hemorrhage , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Stem Cell Transplantation , Stem Cells , Unrelated Donors , Vidarabine
SELECTION OF CITATIONS
SEARCH DETAIL